Nutrigenomics, Metabolic Correction and Disease
Michael J Gonzalez, DSc, NMD, PhD, FACN
Jorge R Miranda-Massari, PharmD
Jorge Duconge, PhD
Jose R Rodriguez, DSc, PhD, MD
Kenneth Cintron, MD, FAAOS, ABIHM
Miguel J Berdiel, MD
Jose W Rodriguez, PhD
PDF
HTML

Keywords

Disease
Epigenetics
Metabolic correction
Nutrigenomics
PDF
HTML

Abstract

Nutrigenomics is the study of the effects of food and food constituents on gene expression. The study of nutrigenomics may have a major impact in the development of tailor-made food, supplements and beverage products in the near future. The “genetic nutritioneering” concept summarizes the information on how diet, supplements, lifestyle and environmental factors influence gene expression. In order to overcome their particular genetic pre-disposition that can lead to serious diseases, people may be able to choose customized diets, supplements and make lifestyle modifications, which would optimize their metabolic status. Nutrient intake for each person varies according to their unique genetic make-up and individual lifestyle choices. Therefore, it may be possible to “correct” physiological disruptions by implementing “Metabolic Correction” principles. To completely accomplish these goals of optimal health, new international alliances and policies need to be developed and implemented and more sound, evidence-based research needs to be conducted.

PDF
HTML

References

Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics. 2004; 16:166–177.
http://www.nutraingredients-usa.com/Research/Metabolic-typing-may-bring-dawn-of-personalised-nutrition. Accessed on 10-10-2013 .
http://www.nutraingredients.com/Research/Overweight-people-s-genes-respond-differently-to-dietary-changes-Study. Accessed on 10-15-2013 .
http://www.biologicnr.com/articles-page/what-is-nutrigenomics/ .
Williams RJ. Biochemical individuality and its implications. Chem Eng News. 1947; 25(16):1112–1113.
Williams R. Concept of genetotrophic disease. Nutr Rev. 1950; 8:257–260.
Pauling L. Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may control mental disease. Science. 1968; 160(3825):265–271.
Hoffer A. Orthomolecular treatment of schizophrenia. Orthomolec Psychiat. 1972; 1:46–55.
Pauling L. Some aspects of orthomolecular medicine. J Intern Acad Prev Med. 1974; 1:1–30.
Baker SM, Bennett P, Bland JS, Galland L, Hedaya RJ , Houston M, Hyman M, Lombard J, Roundtree R, Vasquez A. Textbook of Functional Medicine, 2nd edn. WA: Institute for Functional Medicine; 2005.
Ames BN. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA. 2006; 103:17589–17594.
Gonzalez MJ, Miranda-Massari JR. Metabolic correction: a functional explanation of orthomolecular medicine. J Orthomolec Med. 2012; 27:13–20.
Schuster GU. Nutrients and gene expression. In: Kaput J, Rodriguez R, eds. Nutritional genomics: discovering the path to personalized nutrition. NY: Wiley and Sons, Inc.; 2006. pp. 153–173.
Bird A. Perceptions of epigenetics. Nature. 2007; 447(7143):396–398.
Jacob RA. Folate, DNA methylation, and gene expression: factors of nature and nurture. Am J Clin Nutr. 2000; 72:903–904.
He C. RNA epigenetics? Nature Chem Biol. 2010; 6(12):863–865.
Fontana L. Nutrition, adiposity and health. Epidemiol Prev. 2007; 31(5):290–294.
Genaro Pde S, Sarkis KS, Martini LA. Effect of caloric restriction on longevity. Arq Bras Endocrinol Metabol. 2009; 53(5):667–672.
Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201–204.
Heilbronn L, Ravussin E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr. 2003; 78(3):361–369.
Jung KJ, Maruyama N, Ishigami A, et al. The redox-sensitive DNA binding sites responsible for age-related downregulation of SMP30 by ERK pathway and reversal by calorie restriction. Antioxid Redox Signal. 2006; 8(3–4):671–680.
Kim HJ, Yu BP, Chung HY. Molecular exploration of age-related NF-kB/IKK downregulation by calorie restriction in rat kidney. Free Radic Biol Med. 2002;15; 32(10):991–1005.
Chandrasekar B, Nelson JF, Colston JT, Freeman GL. Calorie restriction attenuates inflammatory responses to myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2001; 280(5):H2094–H2102.
Chung HY, Kim HJ, Kim JW, Yu BP. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann NY Acad Sci. 2001; 928:327–335.
Kim DH, Kim JY, Yu BP, Chung HY. The activation of NF-kappaB through Akt-induced FOXO1 phosphorylation during aging and its modulation by calorie restriction. Biogerontology. 2008; 9(1):33–47.
Kim MK, Chung SW, Kim DH, et al. Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway. Exp Gerontol. 2010; 45(6):419.
Chung HY, Cesari M, Anton S, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009; 8(1):18–30.
Kim YJ, Kim HJ, No JK, et al. Anti-inflammatory action of dietary fish oil and calorie restriction. Life Sci. 2006; 78(21):2523–2532.
Miliaras S, Anogeianaki A, Meditskou S, et al. Effects of rich-in-fat diets and highly selective COX-2 inhibitors on 7,12-dimethylbenz-(A)-anthracene-induced tumor growth. Int J Immunopathol Pharmacol. 2009; 22(2):323–332.
Jung KJ, Lee EK, Kim JY, et al. Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm Res. 2009; 58(3):143–150.
De Souza Pereira R. Selective cyclooxygenase-2 (COX-2) inhibitors used for preventing or regressing cancer. Recent Pat Anticancer Drug Discov. 2009; 4(2):157–163.
Tunon MJ, García-Mediavilla MV, Sánchez-Campos S, González-Gallego J. Potential of flavonoids as anti-inflammatory agents: modulation of pro-inflammatory gene expression and signal transduction pathways. Curr Drug Metab. 2009; 10(3):256–271.
Cruz-Correa M, Shoskes DA, Sanchez P, et al. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006; 4(8):1035–1038.
García-Mediavilla V, Crespo I, Collado PS, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol. 2007; 557(2–3):221–229.
Sehirli O, Ozel Y, Dulundu E, et al. Grape seed extract treatment reduces hepatic ischemia-reperfusion injury in rats. Phytother Res. 2008; 22(1):43–48.
Rimando AM, Nagmani R, Feller DR, Yokoyama W . Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem. 2005; 53(9):3403–3407.
Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumberg RS, Nagai R, Matsuhashi N. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology. 2001; 120:460–469.
Floyd ZE, Wang ZQ, Kilroy G, Cefalu WT. Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. Metabolism. 2008; 57(7 Suppl 1):S32–S38.
Pinent M, Blade MC, Salvado MJ, et al. Intracellular mediators of procyanidin-induced lipolysis in 3T3-L1 adipocytes. J Agric Food Chem. 2005; 53(2):262–266.
Pinent M, Blade MC, Salvado MJ, et al. Grape-seed derived procyanidins interfere with adipogenesis of 3T3-L1 cells at the onset of differentiation. Int J Obes (Lond). 2005; 29(8):934–941.
Bland J. Genetic Nutritioneering, 1st edn. LA: Keats Publishing Co; 1999.
van Ommen B, Bouwman J, Dragsted LO, Drevon CA, Elliott R, de Groot P, Kaput J, Mathers JC, Müller M, Pepping F, Saito J, Scalbert A, Radonjic M, Rocca-Serra P, Travis A, Wopereis S, Evelo CT. Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes Nutr. 2010; 5(3):189–203.
Su X, Wellen KE, Rabinowitz JD. Metabolic control of methylation and acetylation. Curr Opin Chem Biol. 2015; 30:52–60.
Ames BN. A role for supplements in optimizing health: the metabolic tune-up. Arch Biochem Biophys. 2004; 423(1):227–234.
Miranda-Massari JR, Gonzalez MJ, Jimenez FJ, Allende-Vigo MZ, Duconge J. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011;1; 6(4):260–273.
Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme-binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002; 75:616–658.
McDonald L. The Ultimate Diet 2.0. Austin, TX: Lyle McDonald; 2003.
McDonald L. The Ketogenic Diet: A Complete Guide for the Dieter and Practitioner. Austin, TX: Lyle McDonald; 1998.
Fulgoni VL 3rd, Keast DR, Bailey RL, Dwyer J. Foods, fortificants, and supplements: where do Americans get their nutrients? J Nutr. 2011; 141(10):1847–1854.
Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. J Am Med Assoc. 2002; 287:3127–3129.
Misner B. Food alone may not provide sufficient micronutrients for preventing deficiency. J Int Soc Sports Nutr. 2006; 3(1):51–55.
Orsucci D, Mancuso M, Ienco EC, Simoncini C, Siciliano G, Bonuccelli U. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer’s disease. Curr Neurovasc Res. 2013; 10(1):76–80.
Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X . Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta. 2014; 1842(8):1240–1247.
Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan. 2014; 3:6.
Pagano G, Talamanca AA, Castello G, Cordero MD, d’Ischia M, Gadaleta MN, Pallardó FV, Petrovic´ S, Tiano L, Zatterale A. Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev. 2014; 2014:541230.
Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI, Ortiz N. The bio-energetic theory of carcinogenesis. Med Hypotheses. 2012; 79(4):433–439.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.